Medicinal product Ardeaosmosol Ma 10% (Ma 15%, Ma 20%) contains mannitol as the active substance. The preparation is used to support diuresis in the prevention and therapy of oliguric phase of acute renal failure due to surgery, shock, trauma, burns, supportive therapy of edematous conditions, therapy and prevention of intracranial hypertension. In addition, the preparation is used in forced diuresis to accelerate the elimination of toxic substances with renal clearance in the therapy of intoxication and treatment of intraocular hypertension.
| | Ma 10% | Ma 15% | Ma 20% |
| Active substance: | |||
| Mannitolum | 100,0 g | 150,0 g | 200,0 g |
| Adjuvant: | |||
| Aqua pro iniectione ad | 1000 ml | 1000 ml | 1000 ml |
| Osmotic pressure: | 1 327 kPa | 1 991 kPa | 2 655 kPa |
| pH: | 4,0 - 7,0 | 4,0 - 7,0 | 4,0 - 7,0 |
Infusion solution
Description of the preparation: clear, colourless or no more than slightly yellowish solution
Infusion glass bottle with a rubber stopper and a metallic closure, carton box.
Package size: 1x 80 ml, 1x 100 ml, 1x 250 ml, 1x 500 ml, 20x 80 ml, 20x 100 ml, 10x 250 ml, 10x 500 ml
V rámci projektu „Záruky pro mladé v Jihočeském kraji“,
reg. č. CZ.03.1.48/0.0/0.0/15_004/0000007 jsme v naší
firmě obsadili pracovní místo, které je spolufinancováno
z Evropského sociálního fondu a státního rozpočtu České republiky.
© Copyright 2017 ARDEAPHARMA, a.s.
